A Study of Lorigerlimab in Participants With Advanced Solid Tumors
Trial details
- Registry ID
- NCT06730347
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as MGD019
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of Lorigerlimab in Participants With Advanced Solid TumorsNCT06730347 | MacroGenics | Phase 2 | Recruiting | 2027-07Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |